Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,761
archived clinical trials in
Osteoporosis

MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Madison, WI
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
mi
from
Adelaide,
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
mi
from
Adelaide,
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Saint Louis, MO
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
PTH And Calcium Responses to Exercise (PACE) in Older Adults
PTH And Calcium Responses to Exercise (PACE) in Older Adults
Status: Enrolling
Updated:  3/12/2018
University of Colorado Hospital
mi
from
Aurora, CO
PTH And Calcium Responses to Exercise (PACE) in Older Adults
PTH And Calcium Responses to Exercise (PACE) in Older Adults
Status: Enrolling
Updated: 3/12/2018
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Zoledronic Acid Administration in Acute Spinal Cord Injury
The Efficacy of Zoledronic Acid in the Prevention of Bone Loss in Acute Spinal Cord Injury
Status: Enrolling
Updated:  3/12/2018
Kessler Institute for Rehabilitation
mi
from
West Orange, NJ
Zoledronic Acid Administration in Acute Spinal Cord Injury
The Efficacy of Zoledronic Acid in the Prevention of Bone Loss in Acute Spinal Cord Injury
Status: Enrolling
Updated: 3/12/2018
Kessler Institute for Rehabilitation
mi
from
West Orange, NJ
Click here to add this to my saved trials
High-dose Vitamin D Supplementation for ADT-induced Side Effects
High-dose Vitamin D Supplementation for ADT-induced Side Effects
Status: Enrolling
Updated:  3/16/2018
Wilmot Cancer Center, University of Rochester
mi
from
Rochester, NY
High-dose Vitamin D Supplementation for ADT-induced Side Effects
High-dose Vitamin D Supplementation for ADT-induced Side Effects
Status: Enrolling
Updated: 3/16/2018
Wilmot Cancer Center, University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Vitamin D Deficiency in Elderly African American Women in Central Texas
Vitamin D Deficiency in Elderly African American Women in Central Texas
Status: Enrolling
Updated:  3/28/2018
Family Practice Center
mi
from
Waco, TX
Vitamin D Deficiency in Elderly African American Women in Central Texas
Vitamin D Deficiency in Elderly African American Women in Central Texas
Status: Enrolling
Updated: 3/28/2018
Family Practice Center
mi
from
Waco, TX
Click here to add this to my saved trials
Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation
A Phase III Randomized Study of Zolendronate Bisphosphonate Therapy for the Prevention of Bone Loss in Men With Prostate Cancer Receiving Long-Term Androgen Deprivation
Status: Enrolling
Updated:  4/11/2018
Northwestern University
mi
from
Chicago, IL
Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation
A Phase III Randomized Study of Zolendronate Bisphosphonate Therapy for the Prevention of Bone Loss in Men With Prostate Cancer Receiving Long-Term Androgen Deprivation
Status: Enrolling
Updated: 4/11/2018
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation
A Phase III Randomized Study of Zolendronate Bisphosphonate Therapy for the Prevention of Bone Loss in Men With Prostate Cancer Receiving Long-Term Androgen Deprivation
Status: Enrolling
Updated:  4/11/2018
Veterans Affairs Medical Center - Lakeside Chicago
mi
from
Chicago, IL
Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation
A Phase III Randomized Study of Zolendronate Bisphosphonate Therapy for the Prevention of Bone Loss in Men With Prostate Cancer Receiving Long-Term Androgen Deprivation
Status: Enrolling
Updated: 4/11/2018
Veterans Affairs Medical Center - Lakeside Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation
A Phase III Randomized Study of Zolendronate Bisphosphonate Therapy for the Prevention of Bone Loss in Men With Prostate Cancer Receiving Long-Term Androgen Deprivation
Status: Enrolling
Updated:  4/11/2018
John H Stroger Hospital of Cook County
mi
from
Chicago, IL
Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation
A Phase III Randomized Study of Zolendronate Bisphosphonate Therapy for the Prevention of Bone Loss in Men With Prostate Cancer Receiving Long-Term Androgen Deprivation
Status: Enrolling
Updated: 4/11/2018
John H Stroger Hospital of Cook County
mi
from
Chicago, IL
Click here to add this to my saved trials
Trial of Lithium Carbonate for Treatment of Osteoporosis-pseudoglioma Syndrome
Trial of Lithium Carbonate for Treatment of Osteoporosis Pseudoglioma Syndrome
Status: Enrolling
Updated:  4/24/2018
University of Maryland Amish Research Clinic
mi
from
Lancaster, PA
Trial of Lithium Carbonate for Treatment of Osteoporosis-pseudoglioma Syndrome
Trial of Lithium Carbonate for Treatment of Osteoporosis Pseudoglioma Syndrome
Status: Enrolling
Updated: 4/24/2018
University of Maryland Amish Research Clinic
mi
from
Lancaster, PA
Click here to add this to my saved trials